A carregar...
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
The alkylating agent temozolomide (TMZ) together with maximal safe bulk resection and focal radiotherapy comprises the standard treatment for glioblastoma (GB), a particularly aggressive and lethal primary brain tumor. GB affects 3.2 in 100,000 people who have an average survival time of around 14 m...
Na minha lista:
| Publicado no: | Biomedicines |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783999/ https://ncbi.nlm.nih.gov/pubmed/31505812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines7030069 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|